ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0327

Self-management Strategies and Self-efficacy in Patients Living with Inflammatory Arthritis: Findings from a Quality Improvement Project in a Tertiary Centre

Saadia Sasha Ali1, Karafotias Ioasaf2, Bechman Katie3, Andrew Rutherford4, Sophia Steer3 and Elena Nikiphorou3, 1King's College Hospital, Epsom, United Kingdom, 2King's College Hospital, London, United Kingdom, 3King's College London, London, United Kingdom, 4King's College Hospital, London, United Kingdom

Meeting: ACR Convergence 2023

Keywords: Ankylosing spondylitis (AS), education, patient, Psoriatic arthritis, Qualitative Research, rheumatoid arthritis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, November 12, 2023

Title: (0325–0344) Patient Outcomes, Preferences, & Attitudes Poster I

Session Type: Poster Session A

Session Time: 9:00AM-11:00AM

Background/Purpose: The 2021 EULAR guidelines on self-management have made recommendations (rec) to aid with the implementation of self-management strategies in inflammatory arthritis (IA) (1). Their aim is to support patients and encourage a patient-centred care approach which can improve both patient experience and outcomes in IA. Self-management can increase self-efficacy which can in turn improve adherence and outcomes for several self-management strategies (2). The objectives of this project were two fold; 1) to assess the implementation of self-management recommendations into routine clinical care of IA patients at a large tertiary rheumatology centre in London and 2) to explore how implementation (or not) of these recommendations may affect self-efficacy.

Methods: A retrospective analysis of the records of patients attending IA clinics at a large tertiary centre in London was undertaken from January 2022 to November 2022. Inclusion criteria included a diagnosis of either RA, PsA or AS. Specific questions addressing the uptake of the 2021 EULAR recommendations were developed (Table 1). The electronic notes were reviewed by two fellows who additionally interviewed patients via telephone, to explore whether the recommendations were addressed at their clinical encounter with the health care professional. Questions to the patients included specific ones addressing self-efficacy using the validated general self-efficacy (GSE) scale. Comparisons between groups were done with χ² tests, paired T-tests and Wilcoxon’s Rank sum where appropriate.

Results: Fifty patients were included: 50% with RA, 24% with PsA and 26% with SpA. The mean (SD) age of participants was 48 (13) years. The median DAS was 4 (3-5) in RA, SJC and TJC was 2.0 (0.0-10.0) and 2.0 (0.0-8.0) respectively in PsA patients with the median BASDAI of 4 (2-6) in SpA (Table 1). The median GSE was 14 (12-25), where a higher score indicates more self-efficacy. 78% of patients reported feeling involved in the planning of their care and were made aware of the multidisciplinary team (rec 1). 30% felt they were given enough information on disease management (rec 2). Goals and practical points on physical and psychological interventions (rec 3) were mentioned to 50%. For patients where >50% of the self-management recommendations were addressed the mean GSE was 12.64 compared to a mean of 10.52 when < 50% of self-management recommendations were addressed.

Conclusion: This study demonstrates that self-management recommendations are not fully and consistently addressed in routine clinics. Furthermore, patient self-efficacy was low/moderate suggesting that clinicians need to do better at discussing and supporting self-management strategies to improve self-efficacy which may also improve disease outcomes.

Supporting image 1

Table 1. Baseline characteristics and areas addressed to patients with IA, based on the EULAR 2021 self-management recommendations
*GSE score – Ranges from 10_40, where a higher score indicates more self-efficacy.


Disclosures: S. Ali: None; K. Ioasaf: None; B. Katie: None; A. Rutherford: None; S. Steer: None; E. Nikiphorou: AbbVie/Abbott, 6, Celltrion, 6, Eli Lilly, 6, fresenius, 6, Galapagos, 6, Gilead, 1, 6, Pfizer, 6, Sanofi, 6.

To cite this abstract in AMA style:

Ali S, Ioasaf K, Katie B, Rutherford A, Steer S, Nikiphorou E. Self-management Strategies and Self-efficacy in Patients Living with Inflammatory Arthritis: Findings from a Quality Improvement Project in a Tertiary Centre [abstract]. Arthritis Rheumatol. 2023; 75 (suppl 9). https://acrabstracts.org/abstract/self-management-strategies-and-self-efficacy-in-patients-living-with-inflammatory-arthritis-findings-from-a-quality-improvement-project-in-a-tertiary-centre/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2023

ACR Meeting Abstracts - https://acrabstracts.org/abstract/self-management-strategies-and-self-efficacy-in-patients-living-with-inflammatory-arthritis-findings-from-a-quality-improvement-project-in-a-tertiary-centre/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology